Holen Sie sich die Stockscreener-App
1.58
1.86%
-0.03
Handel nachbörslich:
1.58
Schlusskurs vom Vortag:
$1.61
Offen:
$1.6
24-Stunden-Volumen:
14,847
Relative Volume:
0.03
Marktkapitalisierung:
$183.32M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-3.10M
KGV:
-0.0965
EPS:
-16.3657
Netto-Cashflow:
$-1.93M
1W Leistung:
+0.00%
1M Leistung:
-4.82%
6M Leistung:
-48.30%
1J Leistung:
-80.83%
1-Tages-Spanne:
$1.55
$1.63
1-Wochen-Bereich:
$1.55
$1.66
52-Wochen-Spanne:
$0.95
$8.48
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Vergleichen Sie SXTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
1.58 | 186.80M | 1.93M | -3.10M | -1.93M | -16.37 |
|
ZTS
Zoetis Inc
|
153.06 | 67.56B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.80 | 46.65B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.70 | 43.48B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.54 | 19.74B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
312.06 | 14.01B | 2.99B | 1.21B | 1.13B | 25.06 |
China Sxt Pharmaceuticals Inc Aktie (SXTC) Neueste Nachrichten
Ranking China SXT Pharmaceuticals Inc. among high performing stocks via toolsForecast Cut & Long Hold Capital Preservation Tips - Newser
What institutional flow reveals about China SXT Pharmaceuticals Inc.Profit Target & AI Enhanced Trading Alerts - Newser
China SXT Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Trends & Risk Managed Investment Signals - Newser
Is China SXT Pharmaceuticals Inc. stock entering bullish territoryMarket Risk Summary & Fast Moving Market Watchlists - Newser
How to build a dashboard for China SXT Pharmaceuticals Inc. stock2025 Price Targets & Free Verified High Yield Trade Plans - Newser
Can you recover from losses in China SXT Pharmaceuticals Inc.Fed Meeting & Safe Capital Growth Stock Tips - Newser
Heatmap analysis for China SXT Pharmaceuticals Inc. and competitorsVolume Spike & Real-Time Volume Analysis Alerts - Newser
Live market analysis of China SXT Pharmaceuticals Inc.2025 Volatility Report & Fast Entry High Yield Tips - Newser
Quantitative breakdown of China SXT Pharmaceuticals Inc. recent moveJuly 2025 Pullbacks & Low Risk High Reward Ideas - Newser
How to monitor China SXT Pharmaceuticals Inc. with trend dashboardsJuly 2025 Patterns & Reliable Volume Spike Alerts - Newser
Will China SXT Pharmaceuticals Inc. bounce back from current support [July 2025 Macro Moves]Weekly Sector Rotation Insights - Newser
Tools to assess China SXT Pharmaceuticals Inc.’s risk profileTrade Ideas Based on Fundamental Metrics - Newser
China SXT Pharmaceuticals Inc. stock momentum explainedMarket Ready Picks with Technical Support - Newser
Does China SXT Pharmaceuticals Inc. qualify in momentum factor screeningPortfolio Positioning Strategy With Timing - Newser
Published on: 2025-08-11 23:41:24 - Newser
Statistical indicators supporting China SXT Pharmaceuticals Inc.’s strengthFree Weekly Growth Stock Entry Point Alerts - Newser
Chart overlay techniques for tracking China SXT Pharmaceuticals Inc.Free Trend Analysis for Safer Trades - Newser
Custom strategy builders for tracking China SXT Pharmaceuticals Inc.Machine Learning Intraday Signal Forecast - Newser
Is China SXT Pharmaceuticals Inc. a momentum stockFast Payout Trading Plans - newsyoung.net
Using data models to predict China SXT Pharmaceuticals Inc. stock movementSwing Trade Planning with Consistent Setup - Newser
Key External Factors That Drive China SXT Pharmaceuticals Inc. Stock Price MovementsSector Rotation and Stock Opportunity Analysis - Newser
How sentiment analysis helps forecast China SXT Pharmaceuticals Inc.Free Risk Managed Intraday Trade Alerts - Newser
Is it too late to sell China SXT Pharmaceuticals Inc.Quick Profit Setup with Signal Forecast - Newser
What makes China SXT Pharmaceuticals Inc. stock price move sharplyFree Trade Ready Stock Watch for Short Term - Newser
What Fibonacci levels say about China SXT Pharmaceuticals Inc. reboundFree Fundamental + Technical Hybrid Stock Tips - Newser
Finanzdaten der China Sxt Pharmaceuticals Inc-Aktie (SXTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.29%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):